News Daily News Testosterone Therapy Ups VTE Risk, Even When Indicated Caitlin E. Cox November 12, 2019
News Daily News Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome Todd Neale October 15, 2019
News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019
News Daily News High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin Shelley Wood March 08, 2019
News Daily News Hormone Therapy Ups CV Risk in Transgender Individuals Caitlin E. Cox February 18, 2019
News Daily News VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies L.A. McKeown January 14, 2019